Shows & Panels
- AFCEA Answers
- Ask the CIO
- The Big Data Dilemma
- Carrying On with Continuity of Operations
- Connected Government
- Constituent Servicing
- Continuous Monitoring: Tools and Techniques for Trustworthy Government IT
- The Cyber Imperative
- Cyber Solutions for 2013 and Beyond
- Expert Voices
- Federal Executive Forum
- Federal IT Challenge
- Federal Tech Talk
- Mission-critical Apps in the Cloud
- The Path from Legacy Systems
- The Real Deal on Digital Government
- The Reality of Continuous Monitoring... Is Your Agency Secure?
- Veterans in Private Sector: Making the Transition
Shows & Panels
FDA approves flu vaccine for coming season
Monday - 8/13/2012, 4:18pm EDT
WASHINGTON (AP) - The Food and Drug Administration says it has approved the new flu vaccine for the season beginning this year.
Each year the FDA works with other federal agencies and global health experts to design a vaccine to protect against the three viral strains most likely to cause the flu. This year's vaccine has one strain in common with last year's vaccine, plus two new viral strains.
The vaccine will be manufactured by six companies, including GlaxoSmithKline, Sanofi and Novartis.
According to the Centers for Disease Control and Prevention, between 5 and 20 percent of Americans get the flu each year, leading to 200,000 hospitalizations. Flu-related deaths vary each year and can range from 3,000 to 49,000.
The CDC recommends that everyone older than six months receive an annual flu vaccine.
(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)